• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

IACS-10759 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5751764

IACS-010759 is an orally bioavailable inhibitor of complex I of oxidative phosphorylation of the mitochondrial electron transport chain. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
IACS-10759, Inhibitor
Full Product Name
IACS-10759
Product Gene Name
Product Synonym Names
IACS10759; IACS 10759
Form/Format
Powder
Purity/Purification
99.83%
Preparation and Storage
Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.
Molecular Weight
562.56
Formula
C25H25F3N6O4S
CAS
1570496-34-2
Smiles
Cc1nc(nn1Cc1cccc(c1)N1CCC(CC1)S(C)(=O)=O)-c1nc(no1)-c1ccc(OC(F)(F)F)cc1
Receptor (IC50)
complex I of oxidative phosphorylation
Solubility
DMSO: 30mg/mL), 53.3mM
(<1mg/ml refers to the product slightly soluble or insoluble)

Product Categories/Family for IACS-10759, inhibitor

Product References and Citations for IACS-10759, inhibitor

1. Vangapandu HV, et al. Biological and metabolic effects of IACS-2010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells. Oncotarget. 2018 May 18;9 (38):24980-241991.
2. Lissanu Deribe Y, et al. Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med. 2018 Jul;24 (7):1047-1057.
3. Molina JR, et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018 Jul;24 (7):1036-1046.
4. Protopopova M. IACS-10759: A novel OXPHOS inhibitor which selectively kill tumors with metabolic vulnerabilities. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75 (15 Suppl):Abstract nr 4380. doi:10.1158/1538-7445.AM2015-4380

Other Notes

Small volumes of IACS-10759, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for IACS-10759 purchase

MBS5751764 is an inhibitor targeting IACS-10759.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000